Ballroom
Closing Lunch Plenary — Igniting Health Equity: Visioning Syndemics and Advocacy
BallroomThis plenary session will spark a greater understanding of syndemics by exploring how health conditions intertwined with social determinants create significant health challenges in addition to opportunities to advance health equity positions—particularly among LGBTQ+ communities. The discussion will fuel specialized, patient-centric policies and programs, offering actionable ideas and ideals to address these unique challenges. The session will underscore the importance of inclusive representation in shaping health policies by employing a syndemic framework. This approach fosters a comprehensive approach to health equity and creates supportive environments for all community members, especially those grappling with overlapping social and health challenges in current times.
Breakfast Plenary — Reestablishing the Fundamentals to Help Accelerate PrEP Uptake
Ballroom
This plenary session presented by Gilead will elevate the central role that the community can play in addressing HIV prevention needs and address barriers to pre-exposure prophylaxis (PrEP) uptake and access while providing clarity around the affordability of PrEP. Participants will emphasize the need for a systems change designed to increase the uptake of rapid PrEP initiation for those who could benefit from it.
Lunch Plenary — Government Healthcare Agencies Bringing Synchronicity to Healthcare Delivery
BallroomThis plenary session features senior officials from federal government healthcare agencies discussing their strategic goals and activities toward enhancing health equity, optimizing operations, and strengthening program management in addressing today’s public health challenges across HIV, HCV, STIs, harm reduction and LGBTQ health.
Opening Plenary — Today’s Landscape: The State of HIV, HCV, STIs, Harm Reduction and LGBTQ Health
BallroomThis plenary session will feature subject matter experts in each of the five SYNC focus areas to share the current “state of” and future implications in HIV, HCV, STIs, harm reduction and LGBTQ health.
